The mission of NovaMedica is to create comprehensive therapy solutions for patients and their families to ensure the best result with the help of innovative and efficient medical technologies. The company offers patients new pharmaceutical drugs, technologies and other innovative products and services that have successfully proven themselves in various other countries but have not been available in Russia or the CIS before. Our solutions are intended for medical assistance at all stages, from diagnostics and prevention of diseases to treatment and continuous protection.
We are also prepared to actively communicate with patients and patient organizations in Russia and the CIS to raise awareness of new treatment methods in all areas where our company has competences.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (World Health Organization).
Please inform us of any adverse events that might be associated with our pharmaceutical products:
· via the hotline: +7 (800) 222-49-08
· by e-mail:
Pharmaceutical safety information is extremely important as it helps ensure that medicinal products are being used in an effective and safe manner.
NovaMedica to localize in Russia one of the most popular anti-migraine drugs in the world
21 March 2023
Merry Christmas and Happy New Year!
27 December 2022
15 December 2022
4 Key Priorities for the European Medicines Agency in 2023
02 June 2023
CRISPR-based microbial gene therapy delivers promise
02 June 2023
FDA Releases Final Guidance on Adjusting for Covariates in Randomized Clinical Trials
01 June 2023
Small biotech turns CRISPR against bacteria, reducing E. coli in small early study
01 June 2023